chemocentryx inc (CCXI:NASDAQ GS)
Earnings & Estimates Summary - CHEMOCENTRYX INC (CCXI)
2013 revenues at ChemoCentryx, Inc. totaled $6.1M USD, while annual losses equaled $0.95 per share.
Quarterly Earnings & Estimates - CHEMOCENTRYX INC (CCXI)
ChemoCentryx, Inc.'s Quarterly Earnings
ChemoCentryx, Inc. reported 2nd quarter 2014 losses of $0.28 per share on 08/7/2014.
Annual Earnings & Estimates - CHEMOCENTRYX INC (CCXI)
ChemoCentryx, Inc.'s Annual Earnings
ChemoCentryx, Inc. reported annual 2013 losses of $0.95 per share on 03/15/2014.
Quarterly Revenues - CHEMOCENTRYX INC (CCXI)
ChemoCentryx, Inc.'s Quarterly Revenues
ChemoCentryx, Inc. did not report revenues for the 2nd quarter 2014. However, during the 2nd quarter of the prior year the company reported revenues of $1.9M USD.
Annual Revenues - CHEMOCENTRYX INC (CCXI)
ChemoCentryx, Inc.'s Annual Revenues
ChemoCentryx, Inc. had revenues for the full year 2013 of $6.1M USD. This was 11.8% above the prior year's results.
|Biogen Idec Inc||$425.61 USD||+11.48|
|Bristol-Myers Squibb Co||$66.05 USD||+0.38|
|Incyte Corp||$91.97 USD||+4.06|
|Takeda Pharmaceutical Co Ltd||¥6,646 JPY||+130.00|
|Teva Pharmaceutical Industries Ltd||$56.51 USD||-0.05|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|